Accuray Agrees To Acquire RayStation Licenses For $8M From RaySearch Laboratories
Accuray Incorporated (NASDAQ:ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing
Accuray is buying software licenses from another company for 8 million dollars to help treat cancer patients better. When companies spend money to get new tools, watch if it helps them serve customers and make more sales later.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.